China Renaissance
VC Fund
Beijing, China
China Renaissance is a leading independent investment bank in China. Established in Beijing in 2004, we focus on top Chinese entrepreneurs across a broad range of sectors including TMT, consumer products & services, education, healthcare, financial services and CleanTech. We have more than 60 professionals in two offices in Beijing andShanghai. We offer financial advisory services in private placement and M&A to an extensive network of leading Chinese entrepreneurs. In the past five years we have become the number one advisor to Chinese entrepreneurs and successfully closed over $2 billion worth of transactions. We have received awards The Best Boutique Investment Bank in 2006, 2007, 2008 and 2009.
- Total investments:
- 49
- Last investment:
- Lead investor:
- 35%
Last updated:
For AI agents: llms.txt
Industries China Renaissance invests in
Stages China Renaissance invests in
Countries China Renaissance invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Series A
- $1.4M–$147M
- Series B
- $2.8M–$1.6B
- Series C
- $30M–$308M
Investment Focus
Industry
- Manufacturing 9 (18%)
- Financial Services 9 (18%)
- Internet 6 (12%)
- Software 5 (10%)
- E-Commerce 5 (10%)
Stage
- Series A 9 (18%)
- Series B 9 (18%)
- Series C 8 (16%)
- Series D 5 (10%)
- Venture - Series Unknown 4 (8%)
Country
- China 39 (80%)
- Australia 1 (2%)
- Hong Kong 1 (2%)
- United Arab Emirates 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Charles Kim
Managing Director, United States
|
Managing Director, United States | Total investments: 0 | Find email | |
Fan Bao
Chairman & Chief Executive Officer
|
Chairman & Chief Executive Officer | Total investments: 2 | Find email | |
Jane Zou
Managing Director Group Chief Human Resources Officer
|
Managing Director Group Chief Human Resources Officer | Total investments: 0 | Find email | |
Jason Lam
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Kevin Xie
Managing Director Head of Healthcare Business
|
Managing Director Head of Healthcare Business | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Agent Universe is an agent research and development company that provides data analysis and operational support services. | Seed / May 25, 2026 | ||
| RoboScience is a developer of embodied intelligence technology, focusing on the research and development of Cross Embodiment AI. | $146.8M / Series A / May 06, 2026 | ||
| Mingxin Digital is a financial technology company dedicated to driving industrial credit management with digital technology. | $27.4M / Series B / Jan 02, 2025 | ||
| A new energy provides photovoltaic new energy system application solutions is committed to manufacturing and selling N-type high-efficiency photovoltaic cells, components, and system applications, as well as investing in and integrating power station construction and operation. They offer ecological photovoltaic, urban photovoltaic, and offshore PVsolutions. | Venture - Series Unknown / Feb 14, 2023 | ||
| C1Fund is a closed-end investment company with a focus on companies in the digital assets. | Pre-Seed / Jan 01, 2023 | ||
| Enkirs Semiconductors is a developer of high-quality GaN epi-wafers for power electronics. | Series C / Dec 08, 2022 | ||
| RoboSense (Suteng Innovation Technology Co., Ltd.) is the world leading environment perception solutions provider of autonomous driving LiDAR. The company is striving to deliver the world with cutting-edge robotic perception solutions which can perfectly integrate premium LiDAR hardware, 3D data processing algorithms, and deep learning technology.Through constant technology innovation, the company has made possible for robots to “see” the world with excellent environment perception capability.Registered in 2014, RoboSense is founded by a group of PhDs from Harbin Institute of Technology who have been working on LiDAR technology for more than 7 years. Over the past 4 years of commercialization, RoboSense, centered around LiDAR environment Perception technology has set up a complete operation system integrating R&D, Production, and Marketing.Besides an R&D center with Operation team headquartered in Nanshan District, Shenzhen, China, the company has an R&D center in Beijing and Silicon Valley. Until April 2017, the employee base of the company has exceeded 200 people(production employee excluded) with more than 60% are Postgraduates and PhDs. For a long time, the company has maintained cooperation with world-class educational and research institutes including MIT, HKUST, Tsinghua, and HIT on talent sourcing and academic exchanges. | Venture - Series Unknown / Jun 14, 2022 | ||
|
Grit Science
|
Grit Science is a gene therapeutics firm, that engages in the R&D of liver genes. | $15M / Series A / Mar 02, 2022 | |
| MediTrust Health is a leading medical innovation payment service brand in China. | $308M / Series C / Aug 10, 2021 | ||
| SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energyvehicle charging piles, batteries recycling, and solutions. | $1.6B / Series B / Aug 01, 2021 | ||
| See all 49 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does China Renaissance invest in?
China Renaissance invests primarily in Manufacturing, Financial Services and Internet startups, most often at Series A and Series B stage. Most of the 49 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is China Renaissance's check size?
China Renaissance typically joins rounds of $1.4M–$147M at Series A, $2.8M–$1.6B at Series B and $30M–$308M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds China Renaissance participates in.
How do I contact China Renaissance?
Public channels for China Renaissance include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at China Renaissance?
The team at China Renaissance includes Charles Kim (Managing Director, United States), Fan Bao (Chairman & Chief Executive Officer) and Jane Zou (Managing Director Group Chief Human Resources Officer), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
